Work with LifeSpan to design a custom immunohistochemistry to address your specific biological question. Outsource the entire localization process without having to
worry about finding and characterizing target specific antibodies, sourcing and validating difficult-to-find tissues, and having the ability to interpret the resulting
immunostaining in relation to complex human pathologies.
TCR Screening Services
Test your therapeutic antibodies in immunohistochemistry against a broad panel of normal frozen human tissue types in order to determine potential unintended binding.
Our non-GLP TCR services are designed on the FDA recommendation outlined in their "Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use".
Human (tested or 100% immunogen sequence identity)
Protein G purified
IHC - Paraffin
IHC - Frozen
Flow Cytometry (1:5 - 1:10)
Specificity and Use
Reacts with a PI-linked glycoprotein, Mw 18-20kD found on all types of leucocytes including platelets. The antigen is expressed on many hematopoietic and non-hematopoietic cells. 3H1587 has been shown to stimulate NK activity. * The epitope recognized by 3H1587 is lost after reduction, therefore, non-reducing conditions are required for western blotting techniques.
Flow Cytometry: 1:5-1:10. Western Blot: Non-reducing. Immunohistochemistry: frozen, paraffin. ELISA. Western Blot. Radioimmunoassay. Positive control: Tonsil. The applications listed have been tested for the unmodified form of this product. Other forms have not been tested.
Long term: -20°C; Short term: +4°C. Avoid repeat freeze-thaw cycles.
CD59 is a cell surface glycoprotein that regulates complement-mediated cell lysis, and it is involved in lymphocyte signal transduction. This protein is a potent inhibitor of the complement membrane attack complex, whereby it binds complement C8 and/or C9 during the assembly of this complex, thereby inhibiting the incorporation of multiple copies of C9 into the complex, which is necessary for osmolytic pore formation.